TriSalus Life Sciences (TLSI) Cash from Investing Activities (2022 - 2026)
TriSalus Life Sciences posted quarterly Cash from Investing Activities of -$141000.0 for Q1 2026, up 80.25% year-on-year from -$78223.8 in Q1 2025, and down 243.9% on a QoQ basis from -$41000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) has 5 years of Cash from Investing Activities data on file, last reported at -$141000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 80.25% year-over-year to -$141000.0; the trailing twelve-month figure through Mar 2026 stood at -$265000.0 (up 73.31% YoY), and the FY2025 full-year result was -$838000.0, down 142.9% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$141000.0, down from -$41000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $93000.0 in Q2 2025 and bottomed at -$1.6 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$74000.0 (2023), against an average of -$276352.9.
- Peak annual rise in Cash from Investing Activities reached 255.0% in 2025, while the deepest fall reached 981.82% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$272000.0 in 2022, then sank by 36.76% to -$372000.0 in 2023, then jumped by 86.56% to -$50000.0 in 2024, then climbed by 18.0% to -$41000.0 in 2025, then plunged by 243.9% to -$141000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$141000.0 (Q1 2026), -$41000.0 (Q4 2025), and -$176000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn | -141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141,000.00 |
| Mar 31, 2026 | -141,000.00 |
| Dec 31, 2025 | -41,000.00 |
| Dec 31, 2025 | -41,000.00 |
| Sep 30, 2025 | -176,000.00 |
| Sep 30, 2025 | -176,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | -714,000.00 |
| Mar 31, 2025 | -714,000.00 |
| Dec 31, 2024 | -50,000.00 |
| Dec 31, 2024 | -50,000.00 |
| Sep 30, 2024 | -169,000.00 |
| Sep 30, 2024 | -169,000.00 |
| Jun 30, 2024 | -60,000.00 |
| Jun 30, 2024 | -60,000.00 |
| Mar 31, 2024 | -66,000.00 |
| Mar 31, 2024 | -66,000.00 |
| Dec 31, 2023 | -372,000.00 |
| Dec 31, 2023 | -372,000.00 |
| Sep 30, 2023 | -1.11 Mn |
| Sep 30, 2023 | -1.11 Mn |
| Jun 30, 2023 | -30,000.00 |
| Jun 30, 2023 | -30,000.00 |
| Mar 31, 2023 | -74,000.00 |
| Mar 31, 2023 | -74,000.00 |
| Dec 31, 2022 | -272,000.00 |
| Dec 31, 2022 | -272,000.00 |
| Sep 30, 2022 | -1.61 Mn |
| Sep 30, 2022 | -1.61 Mn |
| Jun 30, 2022 | 80,000.00 |
| Jun 30, 2022 | 80,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Mar 31, 2022 | 11,000.00 |